Podcast Summary

Episode Overview

Podcast: Becker’s Healthcare Podcast
Episode: Lung Nodule Pathways to Profit: Aligning Clinical and Financial Leadership
Date: November 14, 2025
Host: Lucas Voss (Becker’s Healthcare)
Guest: Jason Keller (President, Rayler Share Medical Respite; former COO, University of Chicago Medicine)

In this episode, Lucas Voss interviews Jason Keller about the strategic and operational importance of lung nodule management. The conversation delves into the intersection of clinical and financial leadership in creating profitable yet patient-centered lung cancer pathways, emphasizing early detection, cross-disciplinary collaboration, and technology-enabled care.

Key Discussion Points and Insights

The Importance of Lung Nodule Management in Healthcare

• Magnitude of the Issue:
  • Keller underscores the enormous global spend on lung cancer treatment, projected to reach $89 billion by 2030.

    "I think the estimates are that $89 billion will be spent globally on cancer treatment, for lung cancer in particular, by 2030."
    (Keller, 01:29)

• Early Detection as the Key Driver:
  • Early detection, diagnosis, and timely treatment lead to better patient outcomes, higher margins for health systems (due to surgical candidacy), and reduced reliance on resource-intensive late-stage care.

    "If you find cancer early ... get them to treatment, people have better outcomes... much improved outcomes... The alternative is late detection of cancer, which ends up being high utilization of hospital resources, long hospitalizations, and unfortunately, palliative care."
    (Keller, 01:33–02:25)

Collaboration and Aligning Clinical and Financial Leadership

• Dyad Relationships:
  • Keller highlights the critical importance of partnerships between clinical champions and administrative leaders.

    "In my mind, dyad relationships are absolutely critical in this space. Finding someone who is as passionate about this as I am was absolutely critical."
    (Keller, 02:58)

• Roles and Responsibilities:
  • Administrators bring resources, capital, and care continuum coordination.
  • Clinical leaders (physician champions) drive referral pathways, advocate for patients, educate peers, and focus on outcomes.

    "Set up the program, hand off the reins to my clinical partner, and they're the ones who have really driven the success."
    (Keller, 03:50)

Proven Strategies for Effective Lung Nodule Management

• 1. Expanding Screening Access:

  • Keller recommends routine lung cancer screening at all care sites—not just academic centers—by maximizing CT scanner capacity and accessibility.

    "Offer screening at every site across their care continuum... setting aside time to ensure patients can get timely, timely screening."
    (Keller, 04:55)

• 2. Dedicated Lung Nodule Clinics:

  • Establishing nurse practitioner-led lung nodule clinics is vital for tracking and managing patients post-screening, particularly those who require a ‘watch and wait’ approach.

    "Once you screen, you will get a pipeline of patients who have nodules... setting up generally nurse practitioner-led lung nodule clinics is absolutely critical."
    (Keller, 05:22–05:31)

• 3. Harnessing Technology and AI for Incidental Findings:

  • Many lung nodules are discovered incidentally (e.g., during cardiac CT scans or trauma evaluations). AI tools can help radiologists spot these nodules and trigger necessary follow-up.

    "There are now tools with AI that can detect these nodules... ensure that the patient actually was followed up on it."
    (Keller, 06:29–07:06)

• 4. Continuum of Care and Multiple Touchpoints:

  • Patients may touch numerous teams: radiology, interventional pulmonology, primary care, nodule clinics, surgical and oncology services.

    "So many touch points... that's where collaboration between the administrative leader... and that clinical leader... is so important."
    (Keller, 07:39–08:06)

Impact & Broader Significance

• Clinical & Financial Outcomes:

  • Early detection creates a dual benefit: improved survival for patients and higher-margin procedures for hospitals.
  • The conversation consistently emphasizes patient benefit over profit, despite discussion of financial metrics.

• Call to Action:

  • Keller concludes by urging healthcare leaders to prioritize early detection and proactive lung nodule management as essential for reducing lung cancer mortality.

    "Lung cancer is the deadliest cancer that we face... It's absolutely important that we, as leaders of health systems, focus on detection and management of lung nodules... Because we know that early stage one, stage two cancer... outcomes are much improved. And in the end, that's what this is all about..."
    (Keller, 08:30–09:19)

Notable Quotes & Memorable Moments

• On the stakes of early detection:

  “Early detection and early treatment is the difference between life and death.”
  (Keller, 04:30)

• On collaboration:

  “Administrative support brings the resources necessary... but it’s equally — actually more — important to have that clinical champion.”
  (Keller, 03:30)

• On action for listeners:

  “We can talk about money all day long, but the most important thing is improving outcomes... Lung nodule detection management is absolutely... critical to improving outcomes.”
  (Keller, 09:17)

Timestamps for Important Segments

• 00:26–00:58 — Jason Keller’s introduction and background in hospital ops
• 01:03–02:27 — The scope and impact of lung cancer and nodules
• 02:31–04:21 — Value of collaboration between clinical and financial leaders
• 04:37–07:31 — Strategies: screening expansion, dedicated clinics, AI for incidental findings
• 07:39–08:21 — The patient journey and multi-disciplinary care pathways
• 08:30–09:19 — Final advice: urgency of lung cancer as a healthcare focus

Summary Takeaways

• Lung nodule management—especially early detection—is vital for both optimal patient outcomes and health system sustainability.
• Effective programs require robust, cross-campus screening, dedicated follow-up clinics, technology to close care gaps, and deep collaboration between clinical and financial leaders.
• Focusing on early intervention delivers both life-saving clinical results and strong financial returns, but ultimate emphasis should always be on patient benefit.